Nicole J. Blaine

Nicole J. Blaine

Auto-generated profile, based on publicly available information

Nicole J. Blaine

Department of Chemical Engineering and Applied Chemistry University of Toronto Toronto Ontario Canada

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2026 in Advanced Healthcare Materials
Verified
Journal Article
Open access
PDF file
NBNicole J. Blaine
Nicole J. Blaine
ASArianna Skirzynska
Arianna Skirzynska
ACAllysia A. Chin
Allysia A. Chin
JAJulie Audet
Julie Audet
Molly ShoichetMolly Shoichet
Molly Shoichet
The role of viscoelasticity in cell invasion within the brain extracellular matrix (ECM) is not well understood in the context of glioblastoma (GBM). We designed biomimetic viscoelastic hyaluronan (HA)‐based hydrogels to understand the effect of viscoelasticity on the invasion of heterogeneous glioblastoma stem cells (GSCs) categorized into subgroups based on molecular profile, as Reactive, Invasive, or Constructive. Hydrogel viscoelasticity was introduced to a hyaluronan‐oxime (HAox) hydrogel to varying degrees through the incorporation of one of methyl cellulose, ECM‐based proteins, tenascin C or collagen IV, or hydrazone chemistry. Each HAox‐derived viscoelastic hydrogel exhibited significantly higher stress relaxation than HAox. We demonstrated that heterogeneous patient‐derived GSC lines respond differently to viscoelasticity, with a strong correlation between greater invasion of Reactive GSCs in faster stress‐relaxing matrices. This work highlights the importance of investigating the behavior of GSCs based on their heterogeneous molecular profiles and contributes to the understanding of the role of viscoelasticity in GSC invasion.

18 September 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
GWGuanyu Wang
Guanyu Wang
JSJulia Stille
Julia Stille
RBRichard Boulon
Richard Boulon
CHChristopher Dean Hennecker
Christopher Dean Hennecker
XZXiaocong Zhang
Xiaocong Zhang
NMNicolas Moitessier
Nicolas Moitessier
The global emergence of COVID-19, caused by SARS-CoV-2, has underscored the critical need for effective antivirals against coronaviruses. The 3-chymotrypsin-like protease (3CLpro) of coronavirus has been a primary target for drug development due to its critical role across various coronaviruses. Following our initial report, this study focuses on the structure-based optimization of 3CLpro covalent inhibitors. With the guidance of molecular docking and covalent binding parameters measured from an innovative isothermal titration calorimetry-kinetic competition (ITC-KC) assay, we optimized and synthesized series of potent covalent inhibitors with antiviral activity in cell-based assays.